Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,494 | 49,464 | 48,202 | 59,447 | 90,630 |
| Marketable Securities | 20,165 | 43,720 | 54,868 | 51,402 | 13,421 |
| TOTAL | $82,194 | $94,726 | $105,323 | $113,569 | $107,887 |
| Non-Current Assets | |||||
| PPE Net | 29 | 34 | 39 | 45 | 49 |
| Other Non-Current Assets | 0 | 866 | 940 | 983 | 1,025 |
| TOTAL | $29 | $900 | $979 | $1,028 | $1,074 |
| Total Assets | $82,223 | $95,626 | $106,302 | $114,597 | $108,961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 492 | 559 | 2,631 | 344 | 435 |
| Accrued Expenses | 3,744 | 3,908 | 3,295 | 2,419 | 1,899 |
| TOTAL | $4,236 | $4,467 | $5,926 | $2,763 | $2,334 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,253 | 31,134 | 31,021 | 30,916 | 30,809 |
| TOTAL | $31,253 | $31,134 | $31,021 | $30,916 | $30,809 |
| Total Liabilities | $35,489 | $35,601 | $36,947 | $33,679 | $33,143 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,224 | 59,216 | 59,119 | 59,107 | 54,638 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -254,666 | -240,455 | -230,019 | -217,138 | -206,677 |
| Other shareholders' equity | -113 | -46 | 25 | -127 | -85 |
| TOTAL | $46,734 | $60,025 | $69,355 | $80,918 | $75,818 |
| Total Liabilities And Equity | $82,223 | $95,626 | $106,302 | $114,597 | $108,961 |